MedTech News
.................... by Andrew Celentano
Solving Alzheimer’s with math? Researcher explores the possibilities
What can mathematics reveal about Alzheimer’s disease? Mississippi State University associate professor Shantia Yarahmadian is using mathematical modeling to examine how common metals may influence a protein that forms plaque associated with Alzheimer’s disease—and how potential therapies could alter these processes.
Enzyme USP15 present a promising new target for ovarian cancer treatment
Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%.
Portable device delivers rapid testing for mosquito-borne viruses
With a lot of ingenuity, some creative engineering and a few off-the-shelf items, a University of Florida team led by a virologist and an engineer has created an inexpensive, quick and accurate handheld device that can detect seven mosquito-borne illnesses
Neurotransmitter may help aggressive prostate cancer shut out immune cells from the start
A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.
Experimental gene-silencing therapy offers hope for hepatitis B cure
Chronic hepatitis B is a long-lasting condition caused by the hepatitis B virus (HBV) that affects about 240 million people worldwide. Current antiviral treatments are designed to keep the virus under control, but they are not a cure, and medications are usually taken indefinitely.
Three heart cell receptors share unexpected signal that drives scar formation
Researchers at the Stanford Cardiovascular Institute have characterized an unexpected signaling pathway that helps drive cardiac fibrosis, the buildup of scar tissue that makes the heart stiffer and less able to pump normally.
Experimental chemotherapy uses stealth tactic to activate inside cancer cells
Chemotherapy faces a fundamental problem: The same drugs powerful enough to kill cancer cells can also damage healthy tissue.
Novel CAR-T therapy shows promising safety and durable responses in hard-to-treat multiple myeloma
Patients with relapsed or refractory multiple myeloma often run out of effective treatment options after multiple rounds of therapy.